Randomized clinical trial of adjuvant chemotherapy with S‐1 versus gemcitabine after pancreatic cancer resection

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2168|102|7|746-754

ISSN： 0007-1323

Source： BRITISH JOURNAL OF SURGERY, Vol.102, Iss.7, 2015-06, pp. : 746-754

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 3, 2018-02 ,pp. : 192-202

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727)

By  

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 2980-2985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term survival after resection for non‐pancreatic periampullary cancer followed by adjuvant intra‐arterial chemotherapy and concomitant radiotherapy

By  

HPB, Vol. 17, Iss. 7, 2015-07 ,pp. : 573-579

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized clinical trial of defaecatory function after anterior resection for rectal cancer with high versus low ligation of the inferior mesenteric artery

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 5, 2015-04 ,pp. : 501-508

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trial of Adjuvant Gemcitabine for Pancreatic Cancer: The Jury Is Still Out

By  

Pancreatology, Vol. 7, Iss. 5-6, 2007-09 ,pp. : 548-549

Karger

Access to resources Recommend Favorite